Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 34Leukemia 10Congenital Abnormalities 5Recurrence 4Leukemia, Monocytic, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myelomonocytic, Acute 3Hematologic Neoplasms 3Burkitt Lymphoma 3Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Sarcoma, Myeloid 1Sarcoma, Kaposi 1Sarcoma 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Chromosome Aberrations 1Breast Neoplasms 1Acute Myeloid Leukemia With KMT2A Rearrangement 1AIDS-related Kaposi sarcoma 1

Interventions

liposomal doxorubicin 2Docetaxel 2valspodar 1entinostat 1efineptakin alfa 1Thalidomide 1Sirolimus 1Semaxinib 1SUB1 protein, human 1Gemcitabine 1Filgrastim 1Etoposide 1Daunorubicin 1Cilengitide 1Bortezomib 1Altretamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × AIDS-related Kaposi sarcoma × Daunorubicin × Clear all
NCT00427414 2015-04-29

Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma

AIDS Malignancy Consortium

Phase 1 Terminated
14 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡